Simon Wentworth of ThePhamaLetter.com asked, “How might the outcome of the forthcoming presidential election affect health policy in a country that represents both the largest market for pharmaceuticals, and the most important setting for drug
The McKinsey Global Institute estimates that Generative AI could add $60 to $110 billion in total economic value for pharmaceutical companies. Drug discovery is expected to unlock economic value of $13 to $25 billion with
Sales of GLP-1 agonists obesity drugs Ozempic and Wegovy, which are semaglutides, and Mounjaro and Zepbound, which are tirzepatides, were $6 billion in 2023. Morgan Stanley Research predicts the global market for obesity drugs to
Forbes reported that global spending on AI in the pharmaceutical industry will surpass $3.6 billion by 2026. Almost half of global life science professionals are either using or interested in using AI in their research.
EY estimates that the top twenty biopharma companies have $180 billion in sales at risk from patent expirations between now and 2028. Why isn’t their widespread panic at big pharma’s patent cliffs?! What is a
WOW! What a conference! The 2024 PMSA Annual Conference delivered on pharmaceutical industry advanced commercial analytics content and training, on industry professionals to network with and on the beauty and convenience of the location. From
